02-01-2017, 02:51 AM
DrFirst Acquires VisibilityRx to Optimize Clinical Trial Recruitment with Advanced Patient Matching at the Point of Care
Combined solution will facilitate the connection of eligible patients to potentially life-enhancing clinical trials through multiple channels
ROCKVILLE, Md.—January 31, 2017—DrFirst, a pioneer in electronic prescribing, integrated medication management and secure communication for healthcare, announced today the acquisition of VisibilityRx, a leading provider of clinical trial recruitment services to life sciences, clinical research organizations and pharmacies. This acquisition provides DrFirst’s 60,000 physician clients the ability to easily identify and refer their patients to the latest clinical trials. Additionally, by offering this service directly to physicians, it expands VisibilityRx’s capacity for connecting patients to clinical trial recruitment beyond its traditional pharmacy-centric approach. Terms of the deal were not disclosed.
Patient recruitment costs account for a hefty 32% of clinical trials budgets, according to a Cutting Edge Information study. The combined DrFirst and VisibilityRx solution will help researchers manage these costs through the powerful provider-patient relationship to deliver relevant information about new trials and qualification requirements. Using advanced patient matching, these details are delivered to the provider at the point of encounter, thus accelerating the trial enrollment process, increasing efficiencies and expanding patient treatment options.
“We are excited to welcome VisibilityRx to the DrFirst family and create new opportunities to advance patient participation in the clinical trial process,” said G. Cameron Deemer, president of DrFirst. “The acquisition delivers an existing client base and experienced management and provides us with a comprehensive solution that addresses a need for so many patients, physicians, pharmacies and clinical research organizations. This platform will enhance the value of our partners’ electronic health record and pharmacy products, while also helping providers deliver the newest and most applicable clinical trial information to their patients.”
The current VisibilityRx technology utilizes the relationships consumers have with their retail pharmacies to facilitate the matching of patients with relevant clinical trials. This method has proven effective in raising patient awareness of clinical trials and similar opportunities. By making physicians – and by extension the patient – aware of these opportunities at the point of encounter, DrFirst creates additional opportunities for improving the clinical trial enrollment process.
“Coordinated communications at the point of care and throughout the patient’s prescription experience are essential in the patient care process,” said Joe Rector, president of VisibilityRx. “An additional benefit of VisibilityRx is that it provides DrFirst’s life sciences partners new points of engagement during the patient’s prescription lifetime, enabling them to reinforce critical information with patients. We are excited to join DrFirst and look forward to making VisibilityRx available to a wider variety of end-users.”
About VisibilityRx
VisibilityRx is the leader in precise patient identification and communication solutions for clinical trials, risk evaluation and mitigation strategies (REMS), and market research initiatives. This dedicated focus has allowed it to quickly become the standard utilized, and re-utilized, by many well-known healthcare companies to effectively communicate their messages to their patients. VisibilityRx partners with pharmaceutical manufacturers, clinical research organizations, patient recruitment companies, market research organizations and a host of other companies to reduce the time and cost involved with finding and communicating with patients. For more information, please visit www.visibilityrx.com.
About DrFirst
DrFirst has pioneered healthcare technology solutions that inform the provider-patient point of encounter, optimizing provider access to patient information, enhancing the provider’s clinical view of the patient, and improving care delivery and clinical outcomes. DrFirst’s growth is driven by a commitment to innovation, security and reliability across a wide array of services, including electronic prescribing, medication management, medication adherence, secure messaging and care collaboration. We are proud of our track record of service to greater than 330 EMR/EHR/HIS vendors and an extensive network of providers, hospitals and patients. For more information, please visit www.drfirst.com or connect with us @DrFirst.
DrFirst Media Contact:
Stephanie Fraser
Amendola Communications
734-233-1483
sfraser@acmarketingpr.com